Trial · NCT03320850
Participant flow40
How many started, completed or left each group, period by period.
1 to 20 of 40
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Stage 1: Placebo + Hydrogel Admixture | 18 | |
| Overall Study | STARTED | Stage 1: BOTOX® 100U + Hydrogel Admixture | 12 | |
| Overall Study | STARTED | Stage 1: BOTOX® 300U + Hydrogel Admixture | 18 | |
| Overall Study | STARTED | Stage 1: BOTOX® 400U + Hydrogel Admixture | 22 | |
| Overall Study | STARTED | Stage 1: BOTOX® 500U + Hydrogel Admixture | 19 | |
| Overall Study | STARTED | Stage 2: Placebo + Hydrogel Admixture | 58 | |
| Overall Study | STARTED | Stage 2: BOTOX® 100U + Hydrogel Admixture | 57 | |
| Overall Study | STARTED | Stage 2: BOTOX® 300U + Hydrogel Admixture | 60 | |
| Overall Study | STARTED | Stage 2: BOTOX® 400U + Hydrogel Admixture | 60 | |
| Overall Study | STARTED | Stage 2: BOTOX® 500U + Hydrogel Admixture | 59 | |
| Overall Study | Safety Population | Stage 1: Placebo + Hydrogel Admixture | 18 | |
| Overall Study | Safety Population | Stage 1: BOTOX® 100U + Hydrogel Admixture | 12 | |
| Overall Study | Safety Population | Stage 1: BOTOX® 300U + Hydrogel Admixture | 18 | |
| Overall Study | Safety Population | Stage 1: BOTOX® 400U + Hydrogel Admixture | 22 | |
| Overall Study | Safety Population | Stage 1: BOTOX® 500U + Hydrogel Admixture | 19 | |
| Overall Study | Safety Population | Stage 2: Placebo + Hydrogel Admixture | 57 | |
| Overall Study | Safety Population | Stage 2: BOTOX® 100U + Hydrogel Admixture | 57 | |
| Overall Study | Safety Population | Stage 2: BOTOX® 300U + Hydrogel Admixture | 60 | |
| Overall Study | Safety Population | Stage 2: BOTOX® 400U + Hydrogel Admixture | 60 | |
| Overall Study | Safety Population | Stage 2: BOTOX® 500U + Hydrogel Admixture | 58 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03320850/flow